3 stories mentioning AMPHUpdated 41d ago
Every FINWIRES story that references AMPH, newest first.
Amphastar Pharmaceuticals (AMPH) shares were falling over 4% in late Thursday trading after Wells Fargo downgraded the stock to equal-weight from overweight, and cut its price target to $19 from $30.Trading volume stood at more than 448,000 shares, compared with a daily average of about 592,000.Price: $17.43, Change: $-0.89, Percent Change: -4.86%
Amphastar Pharmaceuticals (AMPH) has an average rating of hold and mean price target of $23.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Amphastar Pharmaceuticals (AMPH) has an average rating of overweight and mean price target of $26.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
